Ronit Satchi-Fainaro

The Blavatnik Center for Drug Discovery at Tel Aviv University integrates biology, chemistry, and computational science to accelerate early-stage drug discovery and development. The private company is located in Israel. It offers facilities and expertise in medicinal chemistry, biological target identification and validation, computer-aided drug design, metabolomics, and high-throughput screening. The center provides services such as protein structure modeling, virtual screening, ligand design, assay development, enzymatic and cell-based screening, peptide and small molecule synthesis, and ADME/toxicity prediction. It emphasizes personalized medicine approaches using patient-derived cellular models and rare disease therapies, employing technologies like AI-driven screening and metabolomic profiling.

Provides healthcare services

Functions as a College/University

The private company is based in Raanana, Israel. It comprises a collective of around 400 healthtech leaders from academia, industry, government, healthcare organizations, and NGOs who collaborate to accelerate healthcare innovation, commercialization, and ecosystem development. Key initiatives include the 8400 leadership program, an intensive fellowship developed with partners such as Harvard Business School Executive Education and Israeli government bodies, designed to cultivate healthtech leadership and foster collaborations. Graduates become active network members engaged in national programs and ecosystem growth projects. The network operates a programs incubator focusing on six critical clusters—talent and skills, infrastructure and resources, funding, policy and regulation, tech transfer, and multinationals and network—to address ecosystem gaps and leverage opportunities. Projects include HealthIL, which has facilitated pilots bridging healthcare and technology, and the Israeli FHIR community (FHIR-IL), promoting standardized healthcare data exchange. 8400 also leads bi-national efforts and initiatives supporting venture formation, commercialization, and cross-border collaboration between Israeli and healthtech sectors. 8400 - The Health Network is an organization founded in 2017 dedicated to advancing Israel’s healthtech and life sciences industry as a major engine for economic growth and health innovation.

Operates as a non-profit organization that provides energy efficiency technology solutions

Van Leer Xenia Ventures in companies located in Israel. The firm targets companies operating in the fields of data driven biotechnology and digital pharma. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.7- 1 million. It also makes follow on investments.

Provides fundamental delivery research, development, regulatory science and clinical translation